Article CommentaryCommentary
Biological Indicators, Process Lethality, and Vapor Phase Hydrogen Peroxide Processes
James Agalloco
PDA Journal of Pharmaceutical Science and Technology September 2025, 79 (5) 556-563; DOI: https://doi.org/10.5731/pdajpst.2024-003033.1
James Agalloco
Agalloco & Associates, PO Box 899, Belle Mead, NJ

References
- 1.↵
- Grignol G.,
- Karle D.,
- Eddington D.,
- Rickloff J.,
- Boris C.
- 2.↵
- Marcos-Martin M.,
- Bardat A.,
- Schmitthaeusler R.,
- Beysens D.
- 3.↵
- Agalloco J.
- 4.↵Medicines and Healthcare Products Regulatory Agency. VHP (Vapour Hydrogen Peroxide) Fragility. MHRA Inspectorate Blog. https://mhrainspectorate.blog.gov.uk/2018/04/20/vhp-vapour-hydrogen-peroxidefragility (accessed August 26, 2025).
- 5.↵European Medicines Agency. Annex 1, Manufacture of Sterile Medicinal Products EMA: London, 2022.
- 6.↵
- Pflug I.
- 7.↵
- Agalloco J.,
- DeSantis P.
- 8.↵International Organization for Standardization, ISO 18472:2006/(R)2010Sterilization of Health Care Products—Biological and Chemical Indicators—Test Equipment. ISO: Geneva, 2010.
- 9.↵U.S. Pharmacopeial Convention, General Chapter <1229.5> Biological Indicators for Sterilization. In USP 39–NF34 Supplement 1, USP: Rockville, MD, 2016.
- 10.↵U.S. Pharmacopeial Convention, General Chapter <1229.11> Vapor Phase Sterilization. In USP 38–NF 33 Supplement 1, USP: Rockville, MD, 2015.
- 11.↵
- Levine I.
- 12.↵
- Sutton S.
- 13.↵
- Agalloco J.
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 79, Issue 5
September/October 2025
Biological Indicators, Process Lethality, and Vapor Phase Hydrogen Peroxide Processes
James Agalloco
PDA Journal of Pharmaceutical Science and Technology Sep 2025, 79 (5) 556-563; DOI: 10.5731/pdajpst.2024-003033.1
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.





